Abstract Purpose: To investigate the anti-neuroinflammatory properties of Carum carvi Linn. (CCE, Umbelliferae) aqueous extract in stimulated BV-2 microglial cells and explore its underlying mechanisms.
INTRODUCTION
Carum carvi Linn from the family Umbelliferae is a globally distributed spice with a long history as a traditional medicinal plant [1] . Traditionally, the dried ripe fruits and leaves of the plant are used in folk medicine especially in the treatment of digestive disorders and as a vegetable in the preparation of soups, salads and sauces [2] .
Experimental studies have revealed several benefits of C. carvi such as anti-dyspeptic, antispasmodic, anti-ulcerogenic, anti-tumor, antioxidant, anti-hyperglycemic, anti-hyperlipidemic and anti-inflammatory properties [3, 4] . Earlier reports from our group demonstrated that the aqueous extract of C. carvi fruit exhibited strong anti-oxidant, adaptogenic and memory enhancing effects in in vitro and in vivo experimental models [5, 6] . However, till date the effect of C. carvi on microglia-mediated neuroinflammation was not elucidated.
Microglia cells are ubiquitously distributed immune cells in the central nervous system (CNS) acting as first-line defense in neuronal injury [7] . Several factors disrupt the internal environment of the brain and trigger microglia activation. Once activated, microglia undergoes morphological changes simultaneously releasing a number of pro-inflammatory cytokines such as tumor necrosis factor α (TNF-α), interleukin (IL)-1β, IL-6, nitric oxide (NO), prostaglandin E2 and toxic free radicals leading to a condition known as neuroinflammation [8] . Neuroinflammation is well known to be closely related with the pathogenesis of several neurodegenerative disorders including Parkinson's and Alzheimer's diseases [8, 9] . Thus, the control of microglial activation has been suggested to be promising therapeutic target in combating neuroinflammatory-mediated neurodegenerative diseases.
It is well documented that microglia can be activated in vitro by lipopolysaccharide (LPS) which enhances the production of immunerelated cytotoxic factors and pro-inflammatory cytokines [10] which resembles the in vivo conditions in the CNS. Therefore, LPS-activated BV-microglia is recognized as an important tool for evaluating neuroinflammatory mechanisms [11] . In the present investigation, aqueous extract of C. carvi was evaluated for its protective effects on LPS-activated neuroinflammatory processes in BV-2 microglial cells and explored its mechanisms involved.
EXPERIMENTAL Plant material and preparation of C. carvi extract
The dried fruit material of C. carvi procured in the month of September 2008 was obtained from Chemiloids, Vijayawada, India. The fruit material was authenticated by Dr Vidyadar, a Botanist at VJ College of Pharmacy and Research Institute, Rajahmundry, India and a voucher specimen (CCE-VJ/08) was deposited in Pharmacognosy Department of VJ College of Pharmacy Herbarium, India. The fruit material (1 kg) was powdered and extracted with boiling water (5 L) for 30 min. The filtrate of C. carvi was evaporated under vacuum below 70 °C in a vacuum drier to give a final yield of 66.63 g. The C. carvi extract (CCE) was dissolved in sterile distilled water, filtered on 0.22 µm filters and stored at -20 °C until use. All reagents used in this study were of highest grade available commercially.
Cell culture and viability assay
Cells were cultured in DMEM supplemented with 5 % FBS and 100 U/mL P-S in a 37 °C humidified incubator with 5 % CO 2 and 95 % O 2 . The cells were seeded at a density of 5 × 105 cells/mL and pretreated for 1 h with various concentrations of CCE followed by incubation with LPS (1 μg/mL). For viability assay, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT, Sigma-Aldrich, St. Louis, MO, USA) assay was used as described previously [12] . The cells were incubated with various concentrations of CCE for 24 h followed by MTT for 4 h, and then 100 μl of isopropanol (in 0.04 M hydrochloric acid) was added to dissolve the formazan crystals. The absorbance was read at 570 nm using the Anthos 2010 spectrophotometer (Salzburg, Austria). Each experiment was conducted in triplicate. Percentage of the cell viability was calculated as (O.D. of extract treated sample/O.D. of nontreated sample) x 100 %.
Nitric oxide assay
Production of NO was assayed by measuring the levels of nitrite in the culture supernatant using colorimetric assay with Griess reagent [13] . BV-2 cells (2 x 10 5 cells/mL) were seeded in 6-well plates in 500 µL complete culture medium and treated with the CCE extract at indicated concentrations for 1 h prior to stimulation with LPS (1 µg/mL) for 2 h. Culture supernatant (50 µL) was reacted with an equal volume of Griess reagent (0.1 % naphthylethylenediamine and 1 % sulfanilamide in (5 % H 3 PO 4 ) in 96-well plates at room temperature in the dark. Nitrite concentrations were determined by using standard solutions of sodium nitrite prepared in the culture medium. The absorbance at 540 nm was read using a PowerWavex Microplate Scanning spectrophotometer (Bio-Tek Instrument, Winooski, VT, USA).
IL-6 and TNF-α production assay

BV-2 microglia cells (1 x 10
5 cells/well) were cultured on 96 well plates and treated with the CCE extract at indicated concentrations (25, 50 and 100 μg/mL) for 1 h and stimulated with LPS (1 µg/mL). At 4 h post-LPS treatment, the cells were collected and the supernatants were evaluated for TNF-α and IL-6 levels individually, using respective murine TNF-α and IL-6 ELISA kits from BD Biosciences (San Jose, CA, USA) according to the manufacturer's instructions.
Nuclear protein extraction and Western blot analysis
Cells were washed in cold PBS three times and lysed in a buffer containing 50 mM Tris-HCl, pH 7.4, 1 % (v/v) Tergitol-type NP-40 (NP-40), 0.25 % sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 25 mM NaF, 2 mM Sodium orthovanadate (Na3VO4) and protease inhibitor cocktail (Complete MiniTM, Roche, Mannheim, Germany) at 4 °C. The lysate was clarified by centrifugation at 10,000 g for 20 min at 4 °C to remove insoluble components. Cell lysates were normalized for protein content using bicinchoninic acid reagent (Pierce, Rockford, IL, USA). Equal amounts of protein were loaded onto 10 % polyacrylamide gel electrophoresis (PAGE) and separated by standard sodium dodecyl sulphate-PAGE procedure. The proteins were transferred to an NC membrane (S&S, Dassel, Germany) and blocked with 5 % non-fat dry milk in TBS. To detect protein expression, the blots were probed with the specific antibodies followed by the secondary antibodies coupled to horseradish peroxidase (Bio-Rad, Herculus, CA, USA) with β-actin as internal control. The antibodies against inducible nitric oxide synthase (iNOS), cyclooxegenase (COX)-1, COX-2, nuclear factor kappa-B (NF-κB), I kappa B-alpha (IκB-α) and β-actin were purchased from Cell Signaling Technology Inc (Beverly, MA, USA). The immunoreactive proteins on the membrane were detected by chemiluminescence using the West-Save substrate (Lab-Frontier, Seoul, Korea) on X-ray film.
Statistical analysis
All data are presented as mean ± SEM of at least three independent experiments. Statistical analyses were performed with SAS statistical software (SAS Institute, Cray, NC, USA) using one-way analysis of variance, followed by Dunnett's multiple range tests. P < 0.05 was considered statistically significant.
RESULTS
Effect of CCE on BV-2 microglial cell viability
As shown in Fig. 1 , CCE treatment for 24 h at various concentrations (10-200 µg/mL) did not exhibit any significant cytotoxicity on BV-2 microglial cells. Further, LPS treatment alone (1 μg/ml) also did not show cytotoxicity to BV-2 cells. Therefore the non-toxic concentrations of CCE (25-200 μg/mL) were further used to evaluate the inhibitory properties of CCE in NO production in LPS-stimulated BV-2 cells.
Effect of CCE on LPS-induced NO production in BV-2 cells
As shown in Fig. 2 , cells treated with LPS alone (1 μg/mL) significantly increased the NO levels. Pretreatment with CCE (25, 50, 100 and 200 μg/mL) significantly (p < 0.001 at 100 and 200 μg/mL) and concentration dependently suppressed the LPS-stimulated increase in NO release in BV-2 cells. The maximum effect was observed at a concentration of 100 μg/mL (p < 0.001). Therefore for further experiments we used 25, 50 and 100 μg/mL concentrations of CCE to obtain statistically significant data.
Effect of CCE on LPS-induced expression of iNOS and COX levels
CCE (25, 50 and 100 µg/mL) exhibited a marked inhibitory effect on the expression of iNOS and COX-2 mediators in LPS-stimulated BV-2 cells. The LPS-stimulated increase of protein expression such as iNOS and inducible COX-2 were inhibited in a concentration-dependent manner. However, constitutive COX-1 protein expressional levels were uninterrupted (Fig. 3) .
Effect of CCE on IL-6 and TNF-α production in LPS-stimulated BV-2 cells
LPS stimulation increased the IL-6 and TNF-α level in BV-cells, respectively (p < 0.001). However, pretreatment with CCE significantly (p < 0.01 and p < 0.001 at 50 and 100 μg/mL) and concentration dependently decreased the LPSinduced IL-6 (Fig. 4A) and TNF-α (Fig. 4B ) levels in BV-2 microglial cells. when compared with control group. *p < 0.05, **p < 0.01, ***p < 0.001, compared with LPS alone treated group by one-way analysis of variance, followed by Dunnett's multiple range tests. CCE: Carum carvi extract Figure 5 : Effect of CCE on NF-κB activity in LPS-stimulated BV2 microglia. The expression levels of IκB-α and nuclear translocation of p65 NF-κB in the LPS-stimulated BV-2 cells by indicated concentrations (25, 50 and 100 µg/ml) of the CCE was analyzed by immunoblot analyses with the specific antibodies. The internal control used was β-actin. CCE: Carum carvi extract
Effect of CCE on NF-κB levels in LPSstimulated BV-2 cells
CCE inhibited the LPS-induced phosphorylation and degradation of IκB-α, and nuclear translocation of p65 NF-κB in a concentrationdependent manner (Fig. 5) .
DISCUSSION
Mounting evidence suggest that activation of microglia is the hallmark of neuroinflammation observed in several neurodegenerative diseases and pathological conditions of CNS [8, 9] . Studies have shown that anti-inflammatory agents may suppress microglial activation and thus protect neuronal cell death observed in various neurodegenerative diseases [14, 15] . Activated microglia can produce several potentially neurotoxic substances, including NO, iNOS and COX-2.
It is well documented that microglia produces NO in response to pro-inflammatory stimuli, and iNOS, an important mediator of inflammation speeds up the production of NO [16] . NO which is a neurotransmitter in the CNS has protective functions in anti-inflammatory pathways but at high concentrations it produces nitrite free radicals therefore being neurotoxic [16] . It was reported that COX-2 was markedly up regulated in rodent brain microglia and in BV-2 microglial cells after LPS treatment [17] . Unlike COX-1, COX-2 is normally not present in most cells, but its expression is induced in response to inflammatory cytokines linked to pathological events [18] . In our study, it was observed that CCE significantly suppressed nitrite production in LPS-stimulated BV-2. Further CCE attenuated the increased iNOS and COX-2 expressions without altering the COX-1 expression in LPSstimulated BV-2 cells.
Pro-inflammatory cytokines such as TNF-α and IL-6 cause potent activation of iNOS gene expression in rodent glial cells and muscle cells [19] . The likelihood of the involvement of CCE in attenuating such factors is supported by our observations that proinflammatory mediators produced by LPS treatment such as TNF-α and IL-6 were suppressed by CCE in BV-2 microglial cells suggesting that CCE has potent antineuroinflammatory activity through the inhibition of NO, iNOS, COX-2 and proinflammatory cytokines such as in BV-2 cells TNF-α and IL-6.
NF-κB is an essential and ubiquitous transcription factor for the expression of many inflammation-related genes, including iNOS, COX-2, TNF-α, IL-1β and IL-6. LPS has also been reported to activate NF-κB in microglia [20] . Here, we confirmed that LPS significantly activated NF-κB in BV-2 microglial cells and this activation was inhibited by CCE. It is well established that the nuclear accumulation of NF-κB relies in large part upon IκB kinase-dependent phosphorylation and subsequent degradation of the cytosolic inhibitor, IκB-α. Our result showed that CCE inhibited the LPS-induced phosphorylation/degradation of IκBα and translocation of NF-κB/p65 sub-unit in a concentration-dependent manner. Therefore we believe that CCE majorly targets in regulating NF-κB signaling.
The main constituents of C. carvi are the volatile oils including carvone (40-60 %), limonene, carveol, terpinene, pinene, linalool, cymene, dihydrocarveol and thymol in addition to other glycosides and flavonoids [21, 22] . C. carvi and its active constituents are reported to possess strong anti-oxidant properties [3, 5, 6] . Furthermore, carvone which is majorly present in C. carvi is known to exhibit anti-inflammatory properties by inhibiting the synthesis of leukotrienes and prostaglandins [3] . In light of such reports, our present data support the notion that CCE might play a promising role in exhibiting anti-neuroinflammatory properties in LPSstimulated BV-2 cells.
CONCLUSION
This study revealed that CCE inhibits neuroinflammatory responses in LPS-stimulated BV-2 microglial cells via regulation of NF-κB signaling and has the potential to be developed into a therapeutic agent for the treatment of several neuroinflammatory diseases.
